APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

AI Clinical Trial Design Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Clinical Trial Design Software Market Outlook and Growth Opportunities 2026

Report ID 174539760412 August 2026213 pages

Choose your research edition.

Industry ResearchAI Clinical Trial Design Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Clinical Trial Design Software Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal AI Clinical Trial Design Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Clinical Trial Design Software Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Clinical Trial Design Software Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global AI Clinical Trial Design Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Clinical Trial Design Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Clinical Trial Design Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Clinical Trial Design Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Clinical Trial Design Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Clinical Trial Design Software market include Cytel, TriNetX, Saama, Simulations Plus, Statsols, ConcertAI, Phesi, Faro Health and QuantHealth, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Clinical Trial Design Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Clinical Trial Design Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Clinical Trial Design Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Clinical Trial Design Software market.

AI Clinical Trial Design Software Segment by Company

Cytel

TriNetX

Saama

Simulations Plus

Statsols

ConcertAI

Phesi

Faro Health

QuantHealth

Unlearn

MMS

Berry Consultants

ZS

Clinion

Nurocor

Lindus Health

TrialKey

Protocol Builder

Medidata

IQVIA

Certara

AI Clinical Trial Design Software Segment by Type

End-to-End Trial Design Platforms

Protocol Authoring and Optimization Software

Trial Simulation and Outcome Prediction Software

Adaptive and Bayesian Design Software

Feasibility and Enrollment Design Software

Synthetic Control and Digital Twin Software

AI Clinical Trial Design Software Segment by Application

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Medical Device and Diagnostics Companies

Academic and Medical Research Institutions

Government and Nonprofit Research Organizations

Other Clinical Research Organizations

AI Clinical Trial Design Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Clinical Trial Design Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Clinical Trial Design Software key companies, revenue, market share, and recent developments.

3. To split the AI Clinical Trial Design Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Clinical Trial Design Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Clinical Trial Design Software significant trends, drivers, influence factors in global and regions.

6. To analyze AI Clinical Trial Design Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Trial Design Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Trial Design Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Trial Design Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Clinical Trial Design Software industry.

Chapter 3: Detailed analysis of AI Clinical Trial Design Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Clinical Trial Design Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Clinical Trial Design Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Clinical Trial Design Software Industry Trends Table 2. AI Clinical Trial Design Software Industry Drivers Table 3. AI Clinical Trial Design Software Industry Opportunities and Challenges Table 4. AI Clinical Trial Design Software Industry Restraints Table 5. Global AI Clinical Trial Design Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Clinical Trial Design Software Revenue Share by Company (2021-2026) Table 7. Global AI Clinical Trial Design Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Clinical Trial Design Software Key Company Manufacturing Base & Headquarters Table 9. Global AI Clinical Trial Design Software Company, Product Type & Application Table 10. Global AI Clinical Trial Design Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Clinical Trial Design Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of End-to-End Trial Design Platforms Table 15. Significant Companies of Protocol Authoring and Optimization Software Table 16. Significant Companies of Trial Simulation and Outcome Prediction Software Table 17. Significant Companies of Adaptive and Bayesian Design Software Table 18. Significant Companies of Feasibility and Enrollment Design Software Table 19. Significant Companies of Synthetic Control and Digital Twin Software Table 20. Global AI Clinical Trial Design Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global AI Clinical Trial Design Software Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global AI Clinical Trial Design Software Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global AI Clinical Trial Design Software Sales Value Share by Type (2021-2026) Table 24. Global AI Clinical Trial Design Software Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Pharmaceutical and Biotechnology Companies Table 26. Significant Companies of Contract Research Organizations Table 27. Significant Companies of Medical Device and Diagnostics Companies Table 28. Significant Companies of Academic and Medical Research Institutions Table 29. Significant Companies of Government and Nonprofit Research Organizations Table 30. Significant Companies of Other Clinical Research Organizations Table 31. Global AI Clinical Trial Design Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Clinical Trial Design Software Sales Value by Application (2021-2026) & (US$ Million) Table 33. Global AI Clinical Trial Design Software Sales Value by Application (2027-2032) & (US$ Million) Table 34. Global AI Clinical Trial Design Software Sales Value Share by Application (2021-2026) Table 35. Global AI Clinical Trial Design Software Sales Value Share by Application (2027-2032) Table 36. Global AI Clinical Trial Design Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global AI Clinical Trial Design Software Sales Value by Region (2021-2026) & (US$ Million) Table 38. Global AI Clinical Trial Design Software Sales Value Share by Region (2021-2026) Table 39. Global AI Clinical Trial Design Software Sales Value by Region (2027-2032) & (US$ Million) Table 40. Global AI Clinical Trial Design Software Sales Value Share by Region (2027-2032) Table 41. Global AI Clinical Trial Design Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global AI Clinical Trial Design Software Sales Value by Country (2021-2026) & (US$ Million) Table 43. Global AI Clinical Trial Design Software Sales Value Market Share by Country (2021-2026) Table 44. Global AI Clinical Trial Design Software Sales Value by Country (2027-2032) & (US$ Million) Table 45. Global AI Clinical Trial Design Software Sales Value Market Share by Country (2027-2032) Table 46. Cytel Company Information Table 47. Cytel Business Overview Table 48. Cytel AI Clinical Trial Design Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Cytel AI Clinical Trial Design Software Product Portfolio Table 50. Cytel Recent Development Table 51. TriNetX Company Information Table 52. TriNetX Business Overview Table 53. TriNetX AI Clinical Trial Design Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. TriNetX AI Clinical Trial Design Software Product Portfolio Table 55. TriNetX Recent Development Table 56. Saama Company Information Table 57. Saama Business Overview Table 58. Saama AI Clinical Trial Design Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Saama AI Clinical Trial Design Software Product Portfolio Table 60. Saama Recent Development Table 61. Simulations Plus Company Information Table 62. Simulations Plus Business Overview Table 63. Simulations Plus AI Clinical Trial Design Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Simulations Plus AI Clinical Trial Design Software Product Portfolio Table 65. Simulations Plus Recent Development Table 66. Statsols Company Information Table 67. Statsols Business Overview Table 68. Statsols AI Clinical Trial Design Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Statsols AI Clinical Trial Design Software Product Portfolio Table 70. Statsols Recent Development Table 71. ConcertAI Company Information Table 72. ConcertAI Business Overview Table 73. ConcertAI AI Clinical Trial Design Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. ConcertAI AI Clinical Trial Design Software Product Portfolio Table 75. ConcertAI Recent Development Table 76. Phesi Company Information Table 77. Phesi Business Overview Table 78. Phesi AI Clinical Trial Design Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Phesi AI Clinical Trial Design Software Product Portfolio Table 80. Phesi Recent Development Table 81. Faro Health Company Information Table 82. Faro Health Business Overview Table 83. Faro Health AI Clinical Trial Design Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Faro Health AI Clinical Trial Design Software Product Portfolio Table 85. Faro Health Recent Development Table 86. QuantHealth Company Information Table 87. QuantHealth Business Overview Table 88. QuantHealth AI Clinical Trial Design Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. QuantHealth AI Clinical Trial Design Software Product Portfolio Table 90. QuantHealth Recent Development Table 91. Unlearn Company Information Table 92. Unlearn Business Overview Table 93. Unlearn AI Clinical Trial Design Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Unlearn AI Clinical Trial Design Software Product Portfolio Table 95. Unlearn Recent Development Table 96. MMS Company Information Table 97. MMS Business Overview Table 98. MMS AI Clinical Trial Design Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. MMS AI Clinical Trial Design Software Product Portfolio Table 100. MMS Recent Development Table 101. Berry Consultants Company Information Table 102. Berry Consultants Business Overview Table 103. Berry Consultants AI Clinical Trial Design Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Berry Consultants AI Clinical Trial Design Software Product Portfolio Table 105. Berry Consultants Recent Development Table 106. ZS Company Information Table 107. ZS Business Overview Table 108. ZS AI Clinical Trial Design Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. ZS AI Clinical Trial Design Software Product Portfolio Table 110. ZS Recent Development Table 111. Clinion Company Information Table 112. Clinion Business Overview Table 113. Clinion AI Clinical Trial Design Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Clinion AI Clinical Trial Design Software Product Portfolio Table 115. Clinion Recent Development Table 116. Nurocor Company Information Table 117. Nurocor Business Overview Table 118. Nurocor AI Clinical Trial Design Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Nurocor AI Clinical Trial Design Software Product Portfolio Table 120. Nurocor Recent Development Table 121. Lindus Health Company Information Table 122. Lindus Health Business Overview Table 123. Lindus Health AI Clinical Trial Design Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Lindus Health AI Clinical Trial Design Software Product Portfolio Table 125. Lindus Health Recent Development Table 126. TrialKey Company Information Table 127. TrialKey Business Overview Table 128. TrialKey AI Clinical Trial Design Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. TrialKey AI Clinical Trial Design Software Product Portfolio Table 130. TrialKey Recent Development Table 131. Protocol Builder Company Information Table 132. Protocol Builder Business Overview Table 133. Protocol Builder AI Clinical Trial Design Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Protocol Builder AI Clinical Trial Design Software Product Portfolio Table 135. Protocol Builder Recent Development Table 136. Medidata Company Information Table 137. Medidata Business Overview Table 138. Medidata AI Clinical Trial Design Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Medidata AI Clinical Trial Design Software Product Portfolio Table 140. Medidata Recent Development Table 141. IQVIA Company Information Table 142. IQVIA Business Overview Table 143. IQVIA AI Clinical Trial Design Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. IQVIA AI Clinical Trial Design Software Product Portfolio Table 145. IQVIA Recent Development Table 146. Certara Company Information Table 147. Certara Business Overview Table 148. Certara AI Clinical Trial Design Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Certara AI Clinical Trial Design Software Product Portfolio Table 150. Certara Recent Development Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. AI Clinical Trial Design Software Product Image Figure 2. Global AI Clinical Trial Design Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Clinical Trial Design Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. End-to-End Trial Design Platforms Image Figure 8. Protocol Authoring and Optimization Software Image Figure 9. Trial Simulation and Outcome Prediction Software Image Figure 10. Adaptive and Bayesian Design Software Image Figure 11. Feasibility and Enrollment Design Software Image Figure 12. Synthetic Control and Digital Twin Software Image Figure 13. Global AI Clinical Trial Design Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global AI Clinical Trial Design Software Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global AI Clinical Trial Design Software Sales Value Share by Type (2021-2032) Figure 16. Pharmaceutical and Biotechnology Companies Image Figure 17. Contract Research Organizations Image Figure 18. Medical Device and Diagnostics Companies Image Figure 19. Academic and Medical Research Institutions Image Figure 20. Government and Nonprofit Research Organizations Image Figure 21. Other Clinical Research Organizations Image Figure 22. Global AI Clinical Trial Design Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global AI Clinical Trial Design Software Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global AI Clinical Trial Design Software Sales Value Share by Application (2021-2032) Figure 25. Global AI Clinical Trial Design Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 26. Global AI Clinical Trial Design Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 27. North America AI Clinical Trial Design Software Sales Value (2021-2032) & (US$ Million) Figure 28. North America AI Clinical Trial Design Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Europe AI Clinical Trial Design Software Sales Value (2021-2032) & (US$ Million) Figure 30. Europe AI Clinical Trial Design Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Asia-Pacific AI Clinical Trial Design Software Sales Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific AI Clinical Trial Design Software Sales Value Share by Country (%), 2025 VS 2032 Figure 33. South America AI Clinical Trial Design Software Sales Value (2021-2032) & (US$ Million) Figure 34. South America AI Clinical Trial Design Software Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Middle East & Africa AI Clinical Trial Design Software Sales Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa AI Clinical Trial Design Software Sales Value Share by Country (%), 2025 VS 2032 Figure 37. USA AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. USA AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. USA AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Canada AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Canada AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Canada AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Mexico AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Mexico AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Mexico AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Germany AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Germany AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Germany AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. France AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. France AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. France AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. U.K. AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. U.K. AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. U.K. AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Italy AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Italy AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Italy AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Spain AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Spain AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Spain AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Russia AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Russia AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Russia AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Netherlands AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Netherlands AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Netherlands AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Nordic Countries AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Nordic Countries AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Nordic Countries AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. China AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. China AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. China AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Japan AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Japan AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Japan AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. South Korea AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. South Korea AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. South Korea AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. India AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. India AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. India AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Australia AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Australia AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Australia AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Southeast Asia AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Southeast Asia AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Southeast Asia AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Brazil AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Brazil AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Brazil AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Argentina AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Argentina AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Argentina AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Chile AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Chile AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Chile AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Colombia AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Colombia AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Colombia AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Peru AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Peru AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Peru AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Saudi Arabia AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Saudi Arabia AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Saudi Arabia AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Israel AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Israel AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Israel AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. UAE AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. UAE AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. UAE AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Turkey AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Turkey AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Turkey AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Iran AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Iran AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Iran AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Egypt AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Egypt AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Egypt AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Years Considered Figure 122. Research Process Figure 123. Key Executives Interviewed

Scope & coverage.

Types
  • End-to-End Trial Design Platforms
  • Protocol Authoring and Optimization Software
  • Trial Simulation and Outcome Prediction Software
  • Adaptive and Bayesian Design Software
  • Feasibility and Enrollment Design Software
  • Synthetic Control and Digital Twin Software
Applications
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Medical Device and Diagnostics Companies
  • Academic and Medical Research Institutions
  • Government and Nonprofit Research Organizations
  • Other Clinical Research Organizations
Companies covered
  • Cytel
  • TriNetX
  • Saama
  • Simulations Plus
  • Statsols
  • ConcertAI
  • Phesi
  • Faro Health
  • QuantHealth
  • Unlearn
  • MMS
  • Berry Consultants
  • ZS
  • Clinion
  • Nurocor
  • Lindus Health
  • TrialKey
  • Protocol Builder
  • Medidata
  • IQVIA
  • Certara

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Clinical Trial Design Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Clinical Trial Design Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Clinical Trial Design Software Market Dynamics
  1. 2.1 AI Clinical Trial Design Software Industry Trends
  2. 2.2 AI Clinical Trial Design Software Industry Drivers
  3. 2.3 AI Clinical Trial Design Software Industry Opportunities and Challenges
  4. 2.4 AI Clinical Trial Design Software Industry Restraints
3 AI Clinical Trial Design Software Market by Company
  1. 3.1 Global AI Clinical Trial Design Software Company Revenue Ranking in 2025
  2. 3.2 Global AI Clinical Trial Design Software Revenue by Company (2021-2026)
  3. 3.3 Global AI Clinical Trial Design Software Company Ranking (2024-2026)
  4. 3.4 Global AI Clinical Trial Design Software Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Clinical Trial Design Software Company Product Type and Application
  6. 3.6 Global AI Clinical Trial Design Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Clinical Trial Design Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Clinical Trial Design Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Clinical Trial Design Software Market by Type
  1. 4.1 AI Clinical Trial Design Software Type Introduction
  2. 4.1.1 End-to-End Trial Design Platforms
  3. 4.1.2 Protocol Authoring and Optimization Software
  4. 4.1.3 Trial Simulation and Outcome Prediction Software
  5. 4.1.4 Adaptive and Bayesian Design Software
  6. 4.1.5 Feasibility and Enrollment Design Software
  7. 4.1.6 Synthetic Control and Digital Twin Software
  8. 4.2 Global AI Clinical Trial Design Software Sales Value by Type
  9. 4.2.1 Global AI Clinical Trial Design Software Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global AI Clinical Trial Design Software Sales Value by Type (2021-2032)
  11. 4.2.3 Global AI Clinical Trial Design Software Sales Value Share by Type (2021-2032)
5 AI Clinical Trial Design Software Market by Application
  1. 5.1 AI Clinical Trial Design Software Application Introduction
  2. 5.1.1 Pharmaceutical and Biotechnology Companies
  3. 5.1.2 Contract Research Organizations
  4. 5.1.3 Medical Device and Diagnostics Companies
  5. 5.1.4 Academic and Medical Research Institutions
  6. 5.1.5 Government and Nonprofit Research Organizations
  7. 5.1.6 Other Clinical Research Organizations
  8. 5.2 Global AI Clinical Trial Design Software Sales Value by Application
  9. 5.2.1 Global AI Clinical Trial Design Software Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global AI Clinical Trial Design Software Sales Value by Application (2021-2032)
  11. 5.2.3 Global AI Clinical Trial Design Software Sales Value Share by Application (2021-2032)
6 AI Clinical Trial Design Software Regional Value Analysis
  1. 6.1 Global AI Clinical Trial Design Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Clinical Trial Design Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Clinical Trial Design Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Clinical Trial Design Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Clinical Trial Design Software Sales Value (2021-2032)
  7. 6.3.2 North America AI Clinical Trial Design Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Clinical Trial Design Software Sales Value (2021-2032)
  10. 6.4.2 Europe AI Clinical Trial Design Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Clinical Trial Design Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Clinical Trial Design Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Clinical Trial Design Software Sales Value (2021-2032)
  16. 6.6.2 South America AI Clinical Trial Design Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Clinical Trial Design Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Clinical Trial Design Software Sales Value Share by Country, 2025 VS 2032
7 AI Clinical Trial Design Software Country-level Value Analysis
  1. 7.1 Global AI Clinical Trial Design Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Clinical Trial Design Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Clinical Trial Design Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Clinical Trial Design Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Clinical Trial Design Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Clinical Trial Design Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Clinical Trial Design Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cytel
  2. 8.1.1 Cytel Company Information
  3. 8.1.2 Cytel Business Overview
  4. 8.1.3 Cytel AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cytel AI Clinical Trial Design Software Product Portfolio
  6. 8.1.5 Cytel Recent Developments
  7. 8.2 TriNetX
  8. 8.2.1 TriNetX Company Information
  9. 8.2.2 TriNetX Business Overview
  10. 8.2.3 TriNetX AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 TriNetX AI Clinical Trial Design Software Product Portfolio
  12. 8.2.5 TriNetX Recent Developments
  13. 8.3 Saama
  14. 8.3.1 Saama Company Information
  15. 8.3.2 Saama Business Overview
  16. 8.3.3 Saama AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Saama AI Clinical Trial Design Software Product Portfolio
  18. 8.3.5 Saama Recent Developments
  19. 8.4 Simulations Plus
  20. 8.4.1 Simulations Plus Company Information
  21. 8.4.2 Simulations Plus Business Overview
  22. 8.4.3 Simulations Plus AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Simulations Plus AI Clinical Trial Design Software Product Portfolio
  24. 8.4.5 Simulations Plus Recent Developments
  25. 8.5 Statsols
  26. 8.5.1 Statsols Company Information
  27. 8.5.2 Statsols Business Overview
  28. 8.5.3 Statsols AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Statsols AI Clinical Trial Design Software Product Portfolio
  30. 8.5.5 Statsols Recent Developments
  31. 8.6 ConcertAI
  32. 8.6.1 ConcertAI Company Information
  33. 8.6.2 ConcertAI Business Overview
  34. 8.6.3 ConcertAI AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ConcertAI AI Clinical Trial Design Software Product Portfolio
  36. 8.6.5 ConcertAI Recent Developments
  37. 8.7 Phesi
  38. 8.7.1 Phesi Company Information
  39. 8.7.2 Phesi Business Overview
  40. 8.7.3 Phesi AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Phesi AI Clinical Trial Design Software Product Portfolio
  42. 8.7.5 Phesi Recent Developments
  43. 8.8 Faro Health
  44. 8.8.1 Faro Health Company Information
  45. 8.8.2 Faro Health Business Overview
  46. 8.8.3 Faro Health AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Faro Health AI Clinical Trial Design Software Product Portfolio
  48. 8.8.5 Faro Health Recent Developments
  49. 8.9 QuantHealth
  50. 8.9.1 QuantHealth Company Information
  51. 8.9.2 QuantHealth Business Overview
  52. 8.9.3 QuantHealth AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 QuantHealth AI Clinical Trial Design Software Product Portfolio
  54. 8.9.5 QuantHealth Recent Developments
  55. 8.10 Unlearn
  56. 8.10.1 Unlearn Company Information
  57. 8.10.2 Unlearn Business Overview
  58. 8.10.3 Unlearn AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Unlearn AI Clinical Trial Design Software Product Portfolio
  60. 8.10.5 Unlearn Recent Developments
  61. 8.11 MMS
  62. 8.11.1 MMS Company Information
  63. 8.11.2 MMS Business Overview
  64. 8.11.3 MMS AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MMS AI Clinical Trial Design Software Product Portfolio
  66. 8.11.5 MMS Recent Developments
  67. 8.12 Berry Consultants
  68. 8.12.1 Berry Consultants Company Information
  69. 8.12.2 Berry Consultants Business Overview
  70. 8.12.3 Berry Consultants AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Berry Consultants AI Clinical Trial Design Software Product Portfolio
  72. 8.12.5 Berry Consultants Recent Developments
  73. 8.13 ZS
  74. 8.13.1 ZS Company Information
  75. 8.13.2 ZS Business Overview
  76. 8.13.3 ZS AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ZS AI Clinical Trial Design Software Product Portfolio
  78. 8.13.5 ZS Recent Developments
  79. 8.14 Clinion
  80. 8.14.1 Clinion Company Information
  81. 8.14.2 Clinion Business Overview
  82. 8.14.3 Clinion AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Clinion AI Clinical Trial Design Software Product Portfolio
  84. 8.14.5 Clinion Recent Developments
  85. 8.15 Nurocor
  86. 8.15.1 Nurocor Company Information
  87. 8.15.2 Nurocor Business Overview
  88. 8.15.3 Nurocor AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nurocor AI Clinical Trial Design Software Product Portfolio
  90. 8.15.5 Nurocor Recent Developments
  91. 8.16 Lindus Health
  92. 8.16.1 Lindus Health Company Information
  93. 8.16.2 Lindus Health Business Overview
  94. 8.16.3 Lindus Health AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Lindus Health AI Clinical Trial Design Software Product Portfolio
  96. 8.16.5 Lindus Health Recent Developments
  97. 8.17 TrialKey
  98. 8.17.1 TrialKey Company Information
  99. 8.17.2 TrialKey Business Overview
  100. 8.17.3 TrialKey AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  101. 8.17.4 TrialKey AI Clinical Trial Design Software Product Portfolio
  102. 8.17.5 TrialKey Recent Developments
  103. 8.18 Protocol Builder
  104. 8.18.1 Protocol Builder Company Information
  105. 8.18.2 Protocol Builder Business Overview
  106. 8.18.3 Protocol Builder AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Protocol Builder AI Clinical Trial Design Software Product Portfolio
  108. 8.18.5 Protocol Builder Recent Developments
  109. 8.19 Medidata
  110. 8.19.1 Medidata Company Information
  111. 8.19.2 Medidata Business Overview
  112. 8.19.3 Medidata AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Medidata AI Clinical Trial Design Software Product Portfolio
  114. 8.19.5 Medidata Recent Developments
  115. 8.20 IQVIA
  116. 8.20.1 IQVIA Company Information
  117. 8.20.2 IQVIA Business Overview
  118. 8.20.3 IQVIA AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  119. 8.20.4 IQVIA AI Clinical Trial Design Software Product Portfolio
  120. 8.20.5 IQVIA Recent Developments
  121. 8.21 Certara
  122. 8.21.1 Certara Company Information
  123. 8.21.2 Certara Business Overview
  124. 8.21.3 Certara AI Clinical Trial Design Software Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Certara AI Clinical Trial Design Software Product Portfolio
  126. 8.21.5 Certara Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst